1. Home
  2. RELY vs TMDX Comparison

RELY vs TMDX Comparison

Compare RELY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Remitly Global Inc.

RELY

Remitly Global Inc.

HOLD

Current Price

$13.47

Market Cap

2.6B

Sector

Technology

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$136.66

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RELY
TMDX
Founded
2011
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.9B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
RELY
TMDX
Price
$13.47
$136.66
Analyst Decision
Buy
Buy
Analyst Count
10
10
Target Price
$26.00
$133.00
AVG Volume (30 Days)
4.1M
835.5K
Earning Date
11-05-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
170.70
EPS
0.09
2.54
Revenue
$1,544,865,000.00
$566,354,000.00
Revenue This Year
$30.78
$38.84
Revenue Next Year
$18.39
$20.43
P/E Ratio
$142.50
$53.83
Revenue Growth
31.27
41.20
52 Week Low
$12.08
$55.00
52 Week High
$27.32
$156.00

Technical Indicators

Market Signals
Indicator
RELY
TMDX
Relative Strength Index (RSI) 46.70 54.31
Support Level $12.88 $133.50
Resistance Level $13.59 $156.00
Average True Range (ATR) 0.40 8.50
MACD 0.21 0.41
Stochastic Oscillator 75.34 55.98

Price Performance

Historical Comparison
RELY
TMDX

About RELY Remitly Global Inc.

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: